IM Cannabis Corp. (IMCC) appoints Asi Levi as chief financial officer

Rhea-AI Filing Summary

IM Cannabis Corp. appointed Asi Levi as its chief financial officer, effective immediately. He replaces former CFO Uri Birenberg, who resigned from the role for personal reasons.

Levi brings over 15 years of experience in finance and controlling positions, including prior CFO roles at Water Ways Technologies Inc. and DekelOil CI, and controller roles at SciSparc Ltd. and A2Z Cust2Mate Solutions Corp., with expertise in fundraising, financial planning, budgeting, and cash flow management under IFRS and other standards. The company expects to enter into its standard indemnification agreement with Levi on terms consistent with those for its other directors and executive officers, and this leadership change is incorporated by reference into IM Cannabis’s existing registration statements on Form F-3.

Insights

Corporate governance analyst

IM Cannabis installs an experienced CFO as the prior finance chief departs for personal reasons, suggesting a routine but important leadership transition.

IM Cannabis Corp. has appointed Asi Levi as chief financial officer, effective immediately, following the resignation of former CFO Uri Birenberg for personal reasons. A CFO oversees financial reporting, planning, and cash management, so continuity in this role is important for any public company.

Levi’s background includes more than 15 years in finance and controlling roles, such as serving as CFO of Water Ways Technologies Inc. and DekelOil CI, and as controller at SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. The filing notes his experience with fundraising, financial planning, budgeting, and cash flow management under IFRS and other standards, which supports the company’s reporting and capital-raising needs.

The company expects to enter its standard form of indemnification agreement with Levi on the same terms used for other directors and executive officers, indicating no special arrangements. This leadership change is also incorporated by reference into existing registration statements on Form F-3, ensuring that current offering documents reflect the updated management team.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F ☐

CONTENTS

On December 11, 2025, the board of directors of IM Cannabis Corp. (the “Company”) appointed Mr. Asi Levi as the Company’s Chief Financial Officer, effective immediately. Mr. Levi will replace Mr. Uri Birenberg, who resigned from his position as the Company’s Chief Financial Officer for personal reasons.

Mr. Levi has over 15 years of experience in finance and controlling roles, including serving as chief financial officer of Water Ways Technologies Inc. (TSXV: WWT) and DekelOil CI (part of Dekel Agri-Vision Plc (AIM: DKL)), and as controller of SciSparc Ltd. (Nasdaq: SPRC) and A2Z Cust2Mate Solutions Corp. (Nasdaq: AZ). He has overseen fundraising efforts and handled financial planning, budgeting, and cash flow management in compliance with international financial reporting standards (IFRS) and other standards.

In connection with this appointment, the Company expects to enter into its standard form of indemnification agreement with Mr. Levi on the same terms as the indemnification agreements previously entered into between the Company and each of its directors and executive officers. There are no related party transactions involving Mr. Levi required to be disclosed under Item 7.B of Form 20-F.

On December 12, 2025, the Company issued a press release titled “IM Cannabis Appoints Asi Levi as Chief Financial Officer,” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this “Report”).

This Report is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-289571 and 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit No.
99.1	Press Release dated December 12, 2025 titled “IM Cannabis Appoints Asi Levi as Chief Financial Officer”.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IM CANNABIS CORP.
Date: December 12, 2025	By:	/s/ Oren Shuster
	Name:	Oren Shuster
	Title:	Chief Executive Officer and Director

FAQ

Who is the new chief financial officer of IM Cannabis Corp. (IMCC)?

Asi Levi has been appointed as the chief financial officer of IM Cannabis Corp., effective immediately as of December 11, 2025.

Who did Asi Levi replace as CFO at IM Cannabis Corp. (IMCC) and why did they resign?

Asi Levi replaces Uri Birenberg, who resigned from his position as chief financial officer of IM Cannabis Corp. for personal reasons.

What experience does Asi Levi bring to IM Cannabis Corp. (IMCC)?

Asi Levi has over 15 years of experience in finance and controlling roles, including serving as CFO of Water Ways Technologies Inc. and DekelOil CI, and as controller at SciSparc Ltd. and A2Z Cust2Mate Solutions Corp., with work in fundraising, financial planning, budgeting, and cash flow management under IFRS.

Are there any related party transactions involving new CFO Asi Levi at IM Cannabis (IMCC)?

The company states there are no related party transactions involving Asi Levi that are required to be disclosed under Item 7.B of Form 20-F.

Will IM Cannabis Corp. (IMCC) enter an indemnification agreement with Asi Levi?

IM Cannabis expects to enter into its standard form of indemnification agreement with Asi Levi, on the same terms used for its other directors and executive officers.

How is the CFO appointment reflected in IM Cannabis Corp. (IMCC) SEC documents?

The CFO change is reported in a Form 6-K and is incorporated by reference into IM Cannabis Corp.’s registration statements on Form F-3 (File Nos. 333-289571 and 333-288346).